Author

Ioanna Mavrommati

Institute of Cancer ResearchORCID 0000-0002-5436-2619Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:simulation· 1

Frequent Co-Authors

Ahmet AcariD· 1 shared Alvaro Ingles GarcesiD· 1 shared Andrea SottorivaiD· 1 shared Frederick J.H. WhitingiD· 1 shared Rachael NatrajaniD· 1 shared Trevor A. GrahamiD· 1 shared Udai BanerjiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ahmet AcarORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMar 13, 2026

Inference of Cancer Drug Cross Resistance Using Only Single-Drug Exposure Data

Frederick J.H. Whiting, Ioanna Mavrommati, Ahmet Acar…·Trevor A. Graham

This paper identifies cross resistance between cancer drugs using single-drug exposure data, showing that high cross resistance reduces the effectiveness of switching between CDK4/6 inhibitors.

DOI 10.64898/2026.03.10.709822

humanbulk RNA-seq

𝕏 PostBluesky